Sustained release naltrexone effective, safe for opioid users
(HealthDay)—Sustained release technologies for administering the opioid antagonist naltrexone (SRX) seem to be effective with an acceptable adverse event profile, according to a review published online Oct. 22 in the British ...
Nov 1, 2012
0
0